Other OTC:HWAIF

Emerging Markets Report: Follow the Leader

Retrieved on: 
Tuesday, April 9, 2024
Diagnosis, Disease, Biomedical Research, Patient, HPC, Health care, Artificial intelligence, NVDA, AI, WELL, A.I, TSX, Inflammatory bowel disease, Love, NVIDIA, Map, AIDX, Medicine, Medical device

ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- For some time now the market has been in love with Nvidia (NVDA), the behemoth stock which has been to say the least, a bell cow for the market. And while we don’t discuss actual share prices in our pages, preferring to focus instead on the items that historically drive favorable valuations, Nvidia’s price appreciation has been remarkable and is, powered by their revenue growth and the public’s attraction to Artificial Intelligence technology.

Key Points: 
  • And we believe that the intersection of Health Care and Artificial Intelligence is the first half of that formula.
  • With NVIDIA, healthcare institutions can harness the power of AI and high-performance computing (HPC) to define the future of medicine.
  • If the revenue trend continues, analysts, partners, and market interests may follow.
  • And HEALWELL is certainly following the leader, acquiring and developing potentially lucrative Healthcare A.I.

Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028

Retrieved on: 
Wednesday, March 20, 2024
Tendinopathy, Artificiality, Health, Patient, Conditional sentence, History, Artificial intelligence, Lantern, Mantle cell lymphoma, OTCQX, Microsoft HoloLens, Context, Corporation, NEO, Microsoft, Automation, MCL, DHL, Splenic infarction, Diabetes, Risk, PALM, Radiology, Software, Treatment, UiPath, OTCQB, Strategic alliance, Prevalence, Disease, Microsoft Mesh, Hospital, Research, News, WELL, Student, TSX, MPH, Nursing, Machine learning, Diagnosis, TED (conference), OSCE, Growth, Cancer, Trust, Sarcoma, NHL, Appendicitis, Ecosystem, Probability, AIDX, Medical device

A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.

Key Points: 
  • A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.
  • MarketsAndMarkets continued: “Based on component, the AI in medical diagnostics market is bifurcated into software, services, and hardware.
  • The software segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.
  • The hospitals segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.

OTC Markets Group Welcomes HEALWELL AI Inc. to OTCQX

Retrieved on: 
Tuesday, November 21, 2023
OTCQX, AIDX, PLLC, DTC, TSX, Data science, Security (finance)

NEW YORK , Nov. 21, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced HEALWELL AI Inc. (TSX: AIDX; OTCQX: HWAIF), a healthcare technology and data science company, has qualified to trade on the OTCQX® Best Market.

Key Points: 
  • NEW YORK , Nov. 21, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced HEALWELL AI Inc. (TSX: AIDX; OTCQX: HWAIF), a healthcare technology and data science company, has qualified to trade on the OTCQX® Best Market.
  • HEALWELL AI Inc. upgraded to OTCQX from the Pink® market.
  • HEALWELL AI Inc. begins trading today on OTCQX under the symbol “HWAIF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com .
  • Trading on the OTCQX represents a crucial step forward in our U.S. capital markets strategy, allowing us to expand our reach and enhance accessibility for U.S. investors,” said Alexander Dobranowski, CEO of HEALWELL AI.